Three Newly Approved Drugs for Chronic Lymphocytic...

Clinical Lymphoma Myeloma and Leukemia 2015 / 07 Vol. 15; Iss. 7

Three Newly Approved Drugs for Chronic Lymphocytic Leukemia: Incorporating Ibrutinib, Idelalisib, and Obinutuzumab into Clinical Practice

Sanford, David S., Wierda, William G., Burger, Jan A., Keating, Michael J., O'Brien, Susan M.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
15
Language:
english
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2015.02.019
Date:
July, 2015
File:
PDF, 248 KB
english, 2015
Conversion to is in progress
Conversion to is failed